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Following colostrum management training, a randomized field trial was conducted on a California dairy to determine the effect
of supplementing pooled colostrum with either colostrum-derived replacer (CDR) or second-milking colostrum (transition milk)
on failure of passive transfer (FPT) and preweaning morbidity risks. A total of 166 calves were randomly assigned to 4L first-
milking pooled colostrum (treatment 1), 2L first-milking pooled colostrum and 2L of CDR (treatment 2), or 2L first-milking pooled
colostrum and 2L second-milking pooled colostrum (treatment 3). Mean 24-hour serum TP and IgG for treatments 2 (TP 5.2 g/dL,
IgG 15.9 g/L) and 3 (TP 5.4 g/dL, IgG 18.3 g/L) did not statistically differ but were significantly lower than for treatment 1 (TP
5.9 g/dL, IgG 24.6 g/L). Risk of FPT did not differ for treatments 1, 2, and 3 (0.0%, 9.3%, and 1.9%, resp.). Similarly, the preweaning
risk of diarrhea (81.0%, 92.5%, and 87.0%, resp.) or pneumonia (6.9%, 13.2%, and 18.5%, resp.) did not differ between treatments.
Feeding 4L first-milking pooled colostrum resulted in adequate passive transfer. When first-milking pooled colostrum quantity is
inadequate, CDR or second-milking pooled colostrum can be used to supplement the required colostrum volume and IgG mass
without adversely affecting the risks of FPT or preweaning diarrhea and pneumonia.
1. Introduction
Timely ingestion of high quality colostrum is one of the
most important factors affecting both short and long term
calf performance. Calves that ingest >2 L of high quality
colostrum or that have higher levels of serum IgG in the
first week of life have lower morbidity and mortality than
calves with lower serum IgG levels or that ingest insufficient
quantities of high quality colostrum. Adequate passive trans-
fer of immunity has been associated with lower prewean-
ing veterinary costs, improved weight gain, and increased
milk production and longevity in the milking herd [1–4].
Current recommendations to reduce the incidence of failure
of passive transfer of immunity (FPT), defined as serum
Hindawi Publishing Corporation
Veterinary Medicine International
Volume 2014, Article ID 698741, 9 pages
http://dx.doi.org/10.1155/2014/698741
2 Veterinary Medicine International
IgG < 10mg/mL in the first 1 to 7 days of life, include
feeding 3 to 4 L of colostrum containing a minimum of
50mg/mL IgG within the first 1 to 2 hours of birth [3, 5–
8]. Additionally, studies have shown that colostrum with
bacterial counts <100,000 cfu/mL has a superior apparent
efficiency of absorption (AEA) of immunoglobulins than
colostrum with higher bacterial counts, when fed to calves
[5, 9]. Despite these recommendations, a recent survey of US
dairies reported that, among those tested, 40.7% of dairies
had at least one calf with FPT and that 19.2%of all calves fail to
achieve adequate passive transfer of immunity, with calves in
the Western USA experiencing a higher FPT rate than calves
in the Eastern USA [10, 11]. Understanding the underlying
factors contributing to FPT on dairies is essential to reduce
the occurrence of this condition and to improve short term
calf performance and long term dairy productivity.
A management practice contributing to FPT may be
pooling colostrum. Based on a 2007 National Animal Health
Monitoring survey of US dairy herds, Beam and others
estimated that calves fed pooled colostrum were more than
twice as likely to have FPT as calves fed colostrum from an
individual cow [10, 11]. In addition, a recent study conducted
on aCalifornia dairy showed that calves fed pooled colostrum
with a low IgG concentration (21.1 g/L) had significantly
lower 24-hour serum total protein and IgG concentrations
and a significantly higher risk of FPT compared to calves
fed colostrum-derived replacer (CDR) [12]. The California
study also showed that both the colostrum IgG concentration
and the IgG mass fed were significantly higher in the
CDR compared to the pooled colostrum [12]. Pooling can
maintain an adequate supply of colostrum but may result
in lower quality due to dilution of IgG, as cows producing
higher volumes often contribute colostrum with a lower
concentration of immunoglobulins [3]. Immunoglobulins
are present at high concentrations in colostrum, the initial
secretion from the mammary gland following parturition.
While the levels of immunoglobulins decrease rapidly with
each milking, they remain at higher levels than found in
milk for 5–7 days after calving, as the cow transitions to
production of normal milk [13–18]. Intentional or accidental
addition of colostrum from the second or later milkings
(also known as transition milk), to the colostrum pool
can, therefore, lead to dilution of the IgG concentration of
the pooled colostrum. Furthermore, it is common practice
on California dairies to house recently calved cows in the
hospital pen. As such, sick cows, newly admitted into the
hospital pen, may be misidentified in the parlor, allowing
milk from nonfresh cows to be harvested into the colostrum
supply, further contributing to dilution of the IgG in the
colostrum pool. In a recent national study of colostrum
quality in the USA, only 25.6% of pooled colostrum samples
met industry standards for both IgG concentration and
bacterial count compared with 41.2% of nonpooled samples
[19]. Pooling colostrum also increases the risk of exposure to
infectious disease organisms, such as Mycobacterium avium
subsp. paratuberculosis, bovine leukosis virus, and bovine
viral diarrhea virus [20]. Despite the recognized biosecurity
risks and negative effect on passive transfer of immunity
associatedwith feeding pooled colostrum, calves in 16%ofUS
herds with <100 cows and approximately 57% of herds with
>500 cows continue to be fed pooled colostrum [11].
A second, related management factor contributing to
FPT on dairies is a shortage in colostrum supply and, in
response, commercial colostrum supplements and replacer
products have been developed from bovine plasma, serum,
or colostrum [20]. Results of studies evaluating the efficacy
of these products on serum IgG concentrations, rates of
FPT, and preweaning health outcomes in calves are mixed.
Colostrum replacers and supplements derived from plasma
or serum that provided higher doses of IgG (>170 g IgG) were
shown to prevent FPT; however, those with lower IgG doses
were not [21–26]. Similarly, colostrum-derived replacers with
high doses of IgG (>170 g IgG) were shown to prevent FPT;
however, some but not all colostrum-derived replacers and
supplements with lower doses of IgG also prevented FPT
[8, 12, 25, 27–31]. Studies of plasma-derived replacers have
shown either no difference or an increased risk of health
events in calves compared to colostrum, whereas studies of
colostrum-derived replacers have shown both a decreased
and increased risk of health events in calves compared to
colostrum [23, 25, 26, 32]. Feeding pooled colostrum in
conjunction with a CDR has not been evaluated and could
be an effective approach to address colostrum shortages on
dairies.
Thefirst objective of this studywas to evaluate the effect of
implementing colostrummanagement training regarding the
collection and pooling of colostrumon the IgG concentration
in pooled colostrum, on a dairy previously shown to have
low quality, pooled colostrum [12]. For the purposes of this
study, colostrum is defined as the lacteal secretion produced
for the first 5 days of lactation [13, 15–17]; however, only first-
and second-milking colostrum pools were used based on the
milking number from which they were obtained. The second
objective was to conduct a randomized field trial to compare
the effect of feeding first-milking pooled colostrum or first-
milking pooled colostrum followed by either a reconstituted
CDR or second-milking pooled colostrum on the risk of FPT,
morbidity, and mortality in preweaning Jersey and Holstein
calves. Results of this study will help veterinarians and
dairy producers more effectively manage colostrum supply,
ultimately improving calf performance on dairies.
2. Materials and Methods
2.1. Study Herd and Experimental Design. This study was
approved by theUniversity of California atDavis Institutional
Animal Care and Use Committee (approval date 2/22/2012).
The trial was conducted on a Central California Holstein and
Jersey dairy in Tulare County which milked 3,600 cows and
fed unpasteurized pooled colostrum to calves. The dairy was
selected because of its large size, records availability through
the California Dairy Herd Improvement Association’s milk
testing program, and the owner’s interest and willingness to
participate in the study.
In a previous study, pooled colostrum collected from the
study herd had lower IgG concentrations (mean 21.1 g/L, SD
9.76) than the reported average for Southwestern US dairies
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(64.3 g/L, SE = 2.9) which may explain the high proportion
of FPT in the dairy’s calves [12, 19]. Hence, the herd provided
a unique opportunity for colostrum management training to
improve the IgG concentration of pooled colostrum.
2.2. Pretrial Training Period
2.2.1. Colostrum Management Training. Between November
2011 and January 2012, training was provided to the dairy
staff by the study veterinarians to prevent misidentification
of fresh and sick cows in the hospital pen and to eliminate
mixing first- and second-milking colostrum within the same
pool. All cows were milked twice a day and the dairy’s
protocols regarding timing of milking or parlor hygiene
remained unaltered. After calving and prior to the first
milking,maternity pen staff used a degradable colorwax stick
to mark each cow’s hind limb with a line from above the hock
to below the tarsal joint. Only cows with a line contributed
to the first-milking pooled colostrum supply. After the first
milking, a single cross hatch was placed over this line by
the milking staff. Only cows with the single cross hatch
supplied the second-milking colostrum. After the second
milking, another cross hatch was placed to indicate that these
cows were excluded from further colostrum collection. First-
and second-milking pooled colostrum were collected into
receiver containers that had been permanently marked with
the labels “1” and “2”, respectively.
2.2.2. Baseline Estimation of Herd-Level Colostrum IgG Con-
centration. Prior to initiation of the current trial and while
colostrum management training was ongoing, colostrum
samples were collected between November 2011 and January
2012 to evaluate the effect of the colostrum management
training on baseline IgG concentration of the colostrum.
Herd personnel collected a colostrum sample (50mL) from
the first- and second-milking colostrum containers after
each milking. These colostrum samples were frozen on the
dairy at −20∘C and were transported on a weekly basis to
the University of California at Davis, Veterinary Medicine
Teaching and Research Center (VMTRC, Tulare, CA). The
samples were stored at −80∘C until the end of the pretrial
period, at which point all samples were sent to the testing
laboratory (The Saskatoon Colostrum Co. Ltd., Saskatoon,
Canada) for estimation of IgG (g/L) concentration using
radial immunodiffusion.
2.3. Trial Period
2.3.1. Estimation of Sample Size. Sample size for a significant
difference in 24-hour serum IgG among the three groups of
calves estimated for multiple comparisons using the Tukey-
Kramer (Pairwise) method, at a power of 95%, an alpha of
0.05, a minimal detectable difference of 1 unit, and a SD = 2
resulted in a sample size of 50 calves per group. Adding an
additional 20% to account for attrition, the total sample size
of 60 calves per group was estimated.
2.3.2. Colostrum and Feeding Treatments. Cows within the
last 2 weeks of pregnancy were monitored by trained dairy
staff and moved to a group maternity pen upon showing
signs of impending parturition. Calves were separated from
the dam as soon as possible after birth to prevent suckling
and moved to a group pen where they were ear-tagged, had
their navels dipped with 7% iodine tincture, and were fed
colostrum. Jersey heifer calves, Holstein heifer calves, and
Holstein bull calves were enrolled between February and
March, 2012. Jersey bull calves, all cross-breeds, and calves
born between 5 pmand9 pm,Monday throughThursday, and
between 5 pm Friday and 9 pm Sunday were excluded from
enrollment into the study.
Calves were randomly assigned to one of three treatments
using a list of random numbers pregenerated in Excel 2010
(Microsoft, Redmond, WA). The randomization list was
sealed with opaque adhesive notes that were sequentially
removed only at each calf ’s birth to reveal treatment assign-
ment. In treatment 1, calves were fed 4 L of raw, first-milking
pooled colostrum. In treatment 2, calves were fed 2 L of raw,
first-milking pooled colostrum followed immediately by 2 L
of CDR (Calf ’s Choice Total HiCal, Alta Genetics Inc.). In
treatment 3, calves were fed 2 L of raw, first-milking pooled
colostrum followed immediately by 2 L of raw, second-
milking pooled colostrum.
Colostrum was harvested and stored as described for the
pretrial period. First- and second-milking pooled colostrum
were divided into individual plastic nipple bottles, stored at
4∘C until feeding, and warmed prior to feeding. Calves were
fed colostrum harvested on the day of their birth. The CDR
powder was reconstituted according to the manufacturer’s
instruction by dissolving 700 g of the powder in 1.25 L of
warmwater (46–57∘C), ensuring a solvent that provided 100 g
of IgG per dose. Holstein calves that did not suckle after
multiple attempts or failed to ingest the entire volume within
3 hourswere fed the remaining volume via an esophageal tube
feeder. Jersey heifer calves that did not voluntarily ingest 4 L
of colostrum were instead tube-fed a volume of 3 L of their
assigned colostrum treatment.
2.3.3. Preweaning Calf Management. All study calves were
housed in individual, elevated wooden hutches, and given
free choice water and starter grain until weaning at approxi-
mately 60 to 75 days of age. Calves were fed 2 L of pasteurized
waste milk supplemented with milk replacer containing
20% protein and 20% fat, twice a day. In April 2012, the
dairy’s management implemented changes to the calf feeding
program. Changes affected the type and quantity of milk fed
and the number of feedings per day. The youngest study calf
affected by these changes was 20 days old.
2.4. Data Collection and Laboratory Analysis of Samples.
Information recorded for each calf included herd identifica-
tion number, sex, breed, birthdate, dam identification, birth
weight (kg), time to separation from dam (hrs), and time to
colostrum feeding (hrs).
Immediately before and 24 hours after colostrumwas fed,
a blood sample (5mL) from each calf was collected by jugular
venipuncture, allowed to clot, and centrifuged (Model E8, LW
Scientific, Lawrenceville, GA) at 3300 rpm within 30 minutes
of collection. Serum sampleswere harvested, divided into two
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aliquots, and labeled with the calf ID and whether the sample
was collected before or after feeding colostrum.
A sample of pooled colostrum (5mL) fed to each calf was
collected before feeding and labeled with calf ID and milking
number. All samples were frozen at −20∘C, transported on
ice to the VMTRC, and stored at −80∘C until shipment to
the testing laboratory (The Saskatoon Colostrum Co. Ltd.,
Saskatoon, Canada) for further analyses. Serum samples were
analyzed for total protein (g/dL) by digital refractometer.The
IgG (g/L) of the colostrum and serum samples were analyzed
using radial immunodiffusion [27]. All laboratory personnel
were blinded to treatment.
2.4.1. HealthMonitoring. Each calf wasmonitored twice daily
by dairy staff and at least once daily by study personnel
for signs of illness including lethargy, weakness, decreased
appetite, dehydration, fever, abnormal fecal consistency,
cough, increased respiratory rate, ocular or nasal discharge,
drooping ears, and head tilt. All health events and medical
treatments prescribed by the herd veterinarian were recorded
on waterproof cards hanging on each calf hutch. Data on the
health events and treatments for each calf was subsequently
transferred daily to a standard database by study personnel
until the end of follow-up for each calf at approximately 53
(±3) days of age. All personnel monitoring the calves were
blinded to treatment.
The preweaning morbidity events of interest in this study
were diarrhea and pneumonia. To ensure consistency, the
Wisconsin Calf Health Scoring Chart was modified and used
as a guide in the diagnosis of health events [33]. Diarrhea
was defined as a calf passing abnormal, watery feces with a
foul odor (score 2 or 3). Pneumonia was defined as a calf
displaying signs of spontaneous cough and increased respi-
ratory rate, with or without ocular and/or nasal discharge or
otitis (score 2 or 3), except no attempt was made to induce
a cough. A health event that occurred more than seven
days following recovery from a previous health event was
considered a new incident. Health events occurring within
seven days of a previous health event with similar clinical
signs were considered the same incident.
2.5. Statistical Analysis. All statistical analyses were per-
formed using standard statistical software (IBM SPSS Statis-
tics, version 22.0.0, Armonk, NY, IBM Corp.) and were con-
sidered significant if the 𝑃 value was <0.05. Mean ± standard
error of the mean (SE) pooled colostrum IgG concentrations
for the study pretrial and trial periods were calculated and
compared using a one-way ANOVA. For each treatment in
the study, categorical baseline characteristics (sex, breed, time
to separation from dam, and time to colostrum feeding)
were compared using a Pearson chi-square test or Fischer’s
exact test. Continuous baseline characteristics (birth weight,
precolostrum serum total protein, precolostrum serum IgG,
first-milking colostrum IgG, and total IgG fed) were com-
pared among treatments using one-way ANOVA. The AEA
for each calf was calculated using the following formula:
AEA =
Serum IgG (g/L) × Serum volume (L)
IgG Intake (g)
(1)
with plasma volume estimated as 9.9% and 9.7% of birth
weight for Holsteins and Jerseys, respectively [34]. Means of
the AEA of IgG (%) for the treatments were compared using
a one-way ANOVA. Proportions of calves with FPT (defined
as 24-hour postfeeding serum IgG < 10 g/L), diarrhea, and
pneumonia among the treatments were compared using a 𝑍-
test with the alpha level adjusted for multiple comparisons
using the Bonferroni method.
Two separate Cox proportional hazard models were
used to estimate and compare the preweaning hazards for
both diarrhea and pneumonia among treatments. Follow-
up time for all calves occurred from enrollment until just
prior to weaning (53 ± 3 days of age). The proportional
hazards assumption was evaluated graphically and using the
Schoenfeld residuals. Violation in the proportional hazards
assumption was addressed by estimating hazard ratios using
an extended Cox model with time-dependent covariates.
Variables considered in the models were treatment, sex, and
breed.With the exception of treatment, whichwas forced into
each model, all variables were entered into the Cox models
using a backwards stepwise elimination procedure. Variables
were selected for removal if the 𝑃 value for the change in the
log-likelihood ratio was greater than 0.10.
3. Results
3.1. Effect of Colostrum Management Training on Pooled
Colostrum Quality. In the pretrial period, a total of 56 first-
milking pooled colostrum and 66 second-milking pooled
colostrum samples were analyzed. The mean (±SE) IgG
concentrations in these samples were 56.3 g/L (±2.69) and
18.3 g/L (±1.72), respectively. In the trial, a total of 166 first-
milking pooled colostrum and 53 second-milking pooled
colostrum samples were tested.Themean (±SE) IgG concen-
trations in these samples were 65.1 g/L (±1.25) and 25.8 g/L
(±1.81), respectively.The first-milking pooled colostrum from
the trial period had a mean IgG concentration that was
significantly higher than the first-milking pooled colostrum
in the pretrial period (𝑃 = 0.003) and the second-milking
pooled colostrum in both the pretrial and trial periods (𝑃 <
0.001). Similarly, the mean IgG concentration of the pretrial,
first-milking pooled colostrum was significantly higher than
the second-milking pooled colostrum from the pretrial and
trial periods (𝑃 = 0.003). No statistical difference was noted
between the mean IgG concentration of the second-milking
pooled colostrum in the pretrial and trial periods (𝑃 = 0.059);
however this comparison had low statistical power because of
the small number of samples tested.
3.2. Effect of Colostrum Type on Passive Transfer of Immunity,
Preweaning Health, and Survival. A total of 187 calves were
enrolled in the study. Of these, 166 calves comprising 57
Holstein heifers, 85 Holstein bulls, and 24 Jersey heifers
remained eligible for statistical analysis. Of those enrolled,
58, 54, and 54 calves were allocated to treatments 1, 2, and
3, respectively. Of the 21 calves excluded from the analysis,
16 had precolostrum serum IgG concentrations greater than
2.3 g/L (5, 7, and 4 calves from treatments 1, 2, and 3, resp.)
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Table 1: Comparison of baseline characteristics among 3 treatments in a randomized field trial comparing the effects of feeding first-
milking pooled colostrum alone or first-milking pooled colostrum followed by either a colostrum-derived replacer or second-milking pooled
colostrum to newborn Holstein and Jersey calves.
Characteristic Treatment 1
∗ Treatment 2∗ Treatment 3∗
𝑃 value
𝑁 = 58 𝑁 = 54 𝑁 = 54
Sex:𝑁 (%) 0.167†
Female 23 (39.7) 27 (50.0) 31 (57.4)
Male 35 (60.3) 27 (50.0) 23 (42.6)
Breed:𝑁 (%) 0.544†
Holstein 52 (89.7) 45 (83.3) 45 (83.3)
Jersey 6 (10.3) 9 (16.7) 9 (16.7)
Time to separation from dam:𝑁 (%) 0.912†
<1 hour 41 (70.7) 42 (77.8) 39 (72.2)
1–6 hours 15 (25.9) 11 (20.4) 14 (25.9)
6–9 hours 2 (3.4) 1 (1.9) 1 (1.9)
Time to colostrum feeding:𝑁 (%) 0.764†
<1 hour 4 (6.9) 3 (5.6) 4 (7.4)
1–6 hours 44 (75.9) 37 (68.5) 41 (75.9)
6–9 hours 10 (17.2) 14 (25.9) 9 (16.7)
Birth weight (kg): 0.750§
mean (SE‡) 39.02 (0.86) 38.68 (1.05) 37.99 (1.03)
Precolostrum serum total protein (g/dL): 0.689§
mean (SE) 4.44 (0.04) 4.49 (0.04) 4.45 (0.06)
Precolostrum serum IgG (g/L): 0.715§
mean (SE) 0.40 (0.05) 0.45 (0.06) 0.46 (0.06)
First-milking colostrum IgG (g/L): 0.505§
mean (SE) 65.0 (2.16) 67.0 (2.01) 63.4 (2.35)
Second-milking colostrum IgG (g/L): —
mean (SE) — — 25.8 (1.81)
Total IgG fed‖ (g): <0.001§
mean (SE) 255.9a (8.87) 222.1b (4.84) 172.2c (4.75)
∗Treatment 1: 4L 1st-milking pooled colostrum, treatment 2: 2L 1st-milking pooled colostrum followed by 2L colostrum-derived replacer, and treatment 3: 2L
1st-milking pooled colostrum followed by 2L 2nd-milking pooled colostrum.
†Pearson chi-square or Fischer’s exact test with 5% level of significance.
‡SE: standard error.
§One-way ANOVA using the Tukey multiple comparison procedure with 5% level of significance. Means without a common superscript are significantly
different.
‖Total IgG fed for treatment 2 estimated assuming 100 g IgG in colostrum-derived replacer.
due to possible colostrum ingestion prior to sampling [35].
The remaining 5 calves that were excluded consisted of four
calves that died within 48 hours from atresia coli, which was
not apparent at birth (treatment 2: one calf and treatment 3:
three calves), and one calf (treatment 2) that had no 24-hour
serum sample taken. An additional calf (treatment 2) was
euthanized by the dairy at 9 days of age due to a leg injury
and was excluded from analysis of health events. A second-
milking colostrum sample for one calf was not collected;
therefore, comparison of second-milking colostrum IgG
concentration, total IgG fed, and AEA among treatments was
based on 165 calves.
Of the baseline characteristics tested, only total IgG
(g) fed was significantly different among treatments, with
calves fed only first-milking pooled colostrum (treatment 1)
having the highest and calves fed first- and second-milking
pooled colostrum having the lowest (treatment 3) mean total
IgG fed (Table 1). Calves that received only first-milking
pooled colostrum had 24-hour serum TP and IgG that was
significantly higher than calves in the other treatments (𝑃 <
0.001); however, no difference was noted between the calves
fed first-milking pooled colostrum followed by either CDR
or second-milking pooled colostrum (Table 2). Calves that
received first-milking pooled colostrum followed by CDR
(treatment 2) had a significantly lower AEA than calves
that received either first-milking pooled colostrum alone or
a mixture of first- and second-milking pooled colostrum
(𝑃 < 0.001, Table 2). Although numerical differences existed,
no statistical difference was noted in the risk of FPT as
defined by serum IgG < 10 g/L (𝑃 ≥ 0.05) among the
treatments (Table 2). No statistical difference (𝑃 ≥ 0.05) was
noted among treatments for the risk of preweaning diarrhea
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Table 2: Effect of treatment on 24-hour serum total protein and IgG concentrations, apparent efficiency of IgG absorption, and passive
transfer status of Holstein and Jersey calves in a randomized field trial comparing the effect of feeding either first-milking pooled colostrum
alone or first-milking pooled colostrum followed by either a colostrum-derived replacer or second-milking pooled colostrum.
Item Treatment 1
∗ Treatment 2∗ Treatment 3∗
𝑃 value
𝑁 = 58 𝑁 = 54 𝑁 = 54
24-hour serum total protein (g/dL):
mean (SE†) 5.9a (0.08) 5.2b (0.07) 5.4b (0.06) <0.001‡
24-hour serum IgG (g/L):
mean (SE) 24.6a (1.06) 15.9b (0.78) 18.3b (0.66) <0.001‡
Apparent efficiency of IgG absorption (%):
mean (SE) 37.0a (1.14) 26.3b (1.01) 40.0a (1.29) <0.001‡
Failure of passive transfer: % (95% CI)
IgG (<10 g/L) 0.0a (—) 9.3a (1.53, 16.99) 1.9a (0, 5.45) ≥0.05§
∗Treatment 1: 4L 1st-milking pooled colostrum, treatment 2: 2L 1st-milking pooled colostrum followed by 2L colostrum-derived replacer, and treatment 3: 2L
1st-milking pooled colostrum followed by 2L 2nd-milking pooled colostrum.
†SE: standard error.
‡One-way ANOVA using the Tukey multiple comparison procedure with 5% level of significance. Means without a common superscript are significantly
different.
§Column proportions were compared using a 𝑧-test with the alpha adjusted for multiple comparisons using the Bonferroni method.
Means without a common superscript are significantly different at the 5% level.
(treatment 1: 81.0%, 𝑛 = 58, SE = 0.052, treatment 2: 92.5%,
𝑛 = 53, SE = 0.037, and treatment 3: 87.0%, 𝑛 = 54, SE =
0.046) or pneumonia (treatment 1: 6.9%, 𝑛 = 58, SE = 0.034,
treatment 2: 13.2%, 𝑛 = 53, SE = 0.047, and treatment 3: 18.5%,
𝑛 = 54, SE = 0.053). Two calves (treatment 2) died from
diarrhea. No other deaths due to infectious disease occurred
during the study period.
The final Cox model for diarrhea was adjusted for breed
where Jersey calves’ hazard rate ratio (HRR) for diarrhea was
2.13 times that of Holsteins (95% CI (1.35, 3.35), 𝑃 = 0.001).
In comparison, the best-fitting model for pneumonia was
adjusted for gender; however, the hazard for bull compared
to heifer calves was not significant (HRR = 0.39, 95% CI
(0.151, 1.01), 𝑃 = 0.39). In both models, the treatment
variable violated the proportional hazard assumption and a
treatment-time interaction term was forced into the model.
The hazard for diarrhea was not significant for treatment 2 or
3 (HRR = 1.03, 95% CI (0.997, 1.07), 𝑃 = 0.074; HRR = 1.02,
95%CI (0.98, 1.06),𝑃 = 0.332, resp.) compared to treatment 1.
Similarly, the hazards for pneumonia for treatment 2 or 3were
not significant (HRR = 1.04, 95% CI (0.99, 1.09), 𝑃 = 0.100;
HRR = 1.04, 95% CI (0.99, 1.09), 𝑃 = 0.114, resp.) compared
to treatment 1.
4. Discussion
Feeding 4 L of first-milking pooled colostrum to calves
ensured adequate passive transfer of immunity. How-
ever, dairies that properly manage the quality of pooled
colostrum may, at times, experience a shortage of first-
milking colostrum. The current study is the first to inves-
tigate the alternatives of feeding 2 L of first-milking pooled
colostrum followed by either 2 L of CDR or 2 L of second-
milking pooled colostrum. Although mean 24-hour serum
IgG levels were significantly lower in calves fed either alter-
native, mean IgG levels in all groups were excellent [36] and
the risks of FPT and preweaning diarrhea or pneumonia
were not significantly different from calves fed 4 L of first-
milking pooled colostrum.The lack of significant differences
in FPT or preweaning morbidity between treatments could
have been due to a small sample size or the fact that all
treatments delivered a mass of IgG that met or exceeded the
current industry recommendation of feeding 150–200 g IgG
in 3-4 L of colostrum [3, 5–8] and far exceeded the historical
recommendation of 100 g IgG in 2 L of colostrum [37, 38].
In addition, feeding first-milking pooled colostrum fol-
lowed by either CDR or second-milking pooled colostrum
did not result in an increased hazard for either diarrhea
or pneumonia compared to feeding first-milking pooled
colostrum alone. However, these results should be inter-
preted with caution as it is possible that the diet changes
implemented by the dairy management during the follow-
up period affected the risk of diarrhea or pneumonia for
the calves. Improved nutrient intake has been associated
with improved immune function [39]. Therefore, the diet
changes may have provided protection against diarrhea or
pneumonia, biasing the results by decreasing disease inci-
dence. However, at the onset of the diet changes, the youngest
calf was 20 days of age, which is older than the mean age
of onset reported for the major causes of preweaning calf
diarrhea [40]. Therefore, it is possible that the calves had
passed the period of highest risk for diarrhea prior to the
onset of diet changes such that the hazard results for diarrhea
were unaffected. Additionally, survival analysis for diarrhea
in a subset of the data for calves from birth to 20 days of
age showed a nonsignificant hazard for diarrhea (data not
shown), which is in agreement with the results of the Cox
extended model based on the entire follow-up period.
Feeding high quality colostrum is an important manage-
ment tool for ensuring healthy and productive calves. Results
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from this study indicated that dairies with management
practices similar to the study herd could significantly improve
the IgG concentration of first-milking pooled colostrum by
implementing colostrum management training to prevent
misclassification of fresh cows. As withmany large California
dairies, the study dairy housed fresh and sick cows in the same
pen. Before initiation of the colostrum management training
in this herd, there was no formal method to distinguish the
fresh cows in the milking parlor. Thus, colostrum from the
third or later milkings and milk from nonfresh, sick cows
may have been included in the colostrum supply prior to this
study. Misclassification of cows was eliminated through the
colostrum management training, which emphasized proper
identification of cows at their first and second milking and
likely contributed to the significant increase in the IgG
concentration of the first-milking pooled colostrum between
the pretrial and trial periods. However, the training of the
dairy’s staff was provided by veterinarians who were present
on the dairy daily for the first 3 weeks of the pretrial period
and for the duration of the trial period. The level of training
and oversight is not likely to be repeated by veterinarians
working with producers, which may limit the effectiveness
of similar colostrum management training in a field setting.
In addition, this study was conducted on a single dairy and,
hence, may not be generalizable to other dairies.
The study herd offered a unique opportunity to contrast
results of the current trial to results from a previous trial
that compared the effect of CDR or undifferentiated pooled
colostrum on FPT, morbidity, and mortality in preweaning
calves [12, 32]. Calves fed first-milking pooled colostrum
alone in the current study had higher 24-hour serum IgG
concentrations than calves fed pooled colostrum in the pre-
vious study (24.6 g/L and 7.50 g/L, resp.), whereas calves fed
first-milking pooled colostrum followed by CDR had similar
24-hour serum IgG concentrations to calves fed CDR in the
previous study (15.9 g/L and 15.15 g/L, resp.) on this dairy
[12]. In addition, the risk of FPT in calves fed first-milking
pooled colostrum alone was lower in the current study (0.0%,
𝑛 = 58) compared to in the earlier study (70%, 𝑛 = 269)
[12]. Differences in the 24-hour serum IgG concentrations
and FPT between the two studies may have been due to the
increased amount of IgG fed to the calves in the current study
or to differences in apparent efficiency of IgG absorption
between the studies. In the current study, the IgG concentra-
tion in the first-milking pooled colostrum after the colostrum
management training was higher (65.1 g/L) than previous
pooled colostrum IgG concentrations measured from the
same dairy in the earlier study (21.1 g/L) [12] but similar
to the average IgG concentration in pooled colostrum from
dairies in the Southwest region of theUSA (64.3 g/L) [19].The
increase in the IgG concentration of the pooled colostrum
in the current study is likely due to the improved colostrum
collection by the dairy personnel following the colostrum
management training. However, colostrum samples were not
obtained prior to the initiation of the colostrummanagement
training making it impossible to assess the direct effect of
training.
The results of this study indicated that feeding calves
either first-milking pooled colostrum alone or first- and
second-milking pooled colostrum was associated with a
significantly higher AEA than feeding calves first-milking
pooled colostrum followed by CDR. These results are in
contrast with the previous study conducted on this study
dairy where the AEA of calves fed pooled colostrum (28.8%)
was similar to the AEA of calves fed CDR (27.0%) [12].
However, the AEA of the calves fed first-milking pooled
colostrum followed by CDR in the current study was similar
to the AEA of calves fed CDR in the earlier study conducted
on this dairy [12] but was lower than the AEA (35.5 to
38.8%) reported for calves fed CDR in other studies [8,
25]. Colostrum replacer products vary in the postcolostrum
serum IgG concentrations which they can achieve in calves,
despite providing similar amounts of IgG [20]. The use
of different colostrum replacers among these studies may
explain the variable AEA observed. Absorption of IgG across
the intestinal epithelium is a saturable process [41, 42] and
it is possible that other macromolecules present in the
colostrum replacers may compete with the IgG absorption.
Alternatively, differences in AEA observed among this and
other studies may be due to differences in calf management
practices among the studies, such as the amount of colostrum
feedings provided, method of colostrum feeding, or time
from birth to colostrum feeding that may have affected the
calves’ ability to absorb IgG from the colostrum [20, 43].
The results of this trial suggest that colostrum composition,
in addition to volume and mass of IgG, is important in
IgG absorption. Further research is needed to determine
the effect of various macromolecules in colostrum and
colostrum replacers on AEA and, in particular, the impact of
supplementing maternal colostrum with colostrum replacers
of varying composition.
Results of our study showed that dairies that feed high
quality first-milking pooled colostrum can minimize or
eliminate the risk of FPT in calves. Furthermore, during times
of colostrum shortage, the colostrum supply can be extended
by feeding 2 L of first-milking pooled colostrum combined
with either 2 L of CDR or 2 L of second-milking pooled
colostrum without significant differences in the risk of calves
experiencing FPT and preweaning diarrhea or pneumonia.
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